TABLE 6.
Neutralizing antibody | Neutralizing titer for indicated serum sample
|
No. of patients | |
---|---|---|---|
First (HPV DNA−) | Second (HPV DNA+) | ||
Anti-HPV16 | <40 | <40 | 3 |
320 | 160 | 1 | |
Anti-HPV18 | <40 | <40 | 1 |
<40 | 40 | 2 | |
320 | 320 | 1 | |
Anti-HPV52 | <40 | <40 | 4 |
<40 | 80 | 1 | |
<40 | 160 | 1 | |
<40 | 640 | 1 | |
160 | 80 | 1 | |
80 | 40 | 1 | |
Anti-HPV58 | <40 | 320 | 1 |
40 | 40 | 1 | |
80 | 80 | 1 | |
160 | 160 | 1 |